The blood-sugar level in insulin-dependent diabetic patients with end-stage renal disease (ESRD) during hemodialysis treatment is difficult to control. Use of an open-loop device for continuous subcutaneous insulin delivery is preferred in the treatment of uremic diabetics to obtain acceptable glycemic control. We reported our experience of achieving better metabolic control using the micropump instead of intensive conventional insulin administration in diabetic hemodialysis patients.
|Journal||Dialysis and Transplantation|
|Publication status||Published - 1988|
ASJC Scopus subject areas